Related Experiment Video
Updated: Aug 8, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Insights
This study reports a rare inherited disorder of tyrosine metabolism, tyrosinemia I, in a child with severe epilepsy and developmental delay. The findings highlight the critical role of tyrosine and methionine metabolism in the central nervous system.
Area of Science:
- Biochemistry
- Genetics
- Pediatric Neurology
Background:
- Inherited metabolic disorders can present with complex neurological and hepatic symptoms.
- Tyrosinemia I is a rare genetic condition affecting tyrosine metabolism.
- Early diagnosis and understanding of metabolic disturbances are crucial for patient outcomes.
Observation:
- A child presented with intractable seizures and developmental retardation from 10 months of age.
- Jaundice and hepatosplenomegaly developed at 23 months, preceding death at 25 months.
- Elevated methionine and tyrosine levels were observed in urine, plasma, cerebrospinal fluid (CSF), and brain tissue, with higher concentrations in the CNS.
Findings:
- The enzyme 4-hydroxyphenylpyruvate dioxygenase was undetectable in skin fibroblasts and liver.
- Biochemical data strongly indicated an inherited disorder of tyrosine metabolism, specifically tyrosinemia I.
- Metabolic disturbances in tyrosine and methionine within the central nervous system (CNS) were significant.
Implications:
- Tyrosinemia I should be considered in the differential diagnosis of children with unexplained epilepsy and neurological deficits.
- Hepatic dysfunction developing in children on anticonvulsants warrants investigation for underlying metabolic disorders like tyrosinemia I.
- The CNS impact of tyrosine and methionine metabolism disturbances in tyrosinemia I may be underestimated and warrants further research.
Abstract:
A child with intractable seizures from the age of 10 months and developmental retardation developed jaundice and hepatosplenomegaly at 23 months. She died at the age of 25 months. Methionine and tyrosine were elevated in urine, plasma, CSF, and brain. These elevations were more marked in the CNS than in the blood. 4-Hydroxyphenylpyruvate dioxygenase, an enzyme involved in the metabolism of tyrosine, was undetectable in skin fibroblasts and liver. This finding together with other biochemical data suggest that our case had an inherited disorder of tyrosine metabolism, in the category of tyrosinemia I. Disturbances of tyrosine and methionine metabolism in the CNS in tyrosinemia I may be more important than has been realized. The disorder should be considered in children with unexplained epilepsy and in those who develop hepatic dysfunction while on anticonvulsants.
Related Concept Videos
Epistasis
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Seizures ll: Types
Antiprotozoal Agents

